Summary
Dr. Ashish Jha discusses the hantavirus outbreak on a cruise ship, downplaying pandemic risk and explaining symptoms, transmission, and quarantine procedures. He also addresses the status of a potential vaccine and comments on the FDA's current challenges under political pressure.
- Hantavirus outbreak on a cruise ship involves the Andes strain which can spread human-to-human.
- Dr. Jha says the chance of a large global outbreak is exceedingly low.
- Patients are being transferred to Nebraska Medical Center's special pathogen unit out of caution.
- Moderna has early-stage work on a hantavirus vaccine but it is not near prime time.
- Dr. Jha criticizes Secretary Kennedy's blocking of mRNA vaccine development as irrational.
- The FDA is struggling with staff departures and political pressure under Commissioner Marty Makary.